Autoantibody biomarkers for gastric cancer

摘要

This invention provides an improvement for the early diagnosis of GC and development of an effective non-invasive diagnostic and/or prognostic test for gastric cancer. The set goal is achieved by identifying a set of antigens with relevance for diagnosis of GC by using a high-throughput technological platform (i.e., microarray) to analyze autoantibodies in sera from healthy individuals and cancer patients against all of the antigens simultaneously. Eleven antigens are disclosed in SEQ ID NOs 1-11.